Treatment of plasma cell myeloma.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001806:Blood Urea Nitrogen; D002452:Cell Count; D002470:Cell Survival / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D006801:Humans; D007075:Immunoglobulin M / Q000502:physiology; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality / Q000473:pathology; D010950:Plasma Cells / Q000502:physiology; D011379:Prognosis; D050378:T-Lymphocytes, Regulatory / Q000502:physiology
D000970:Antineoplastic Agents; D007075:Immunoglobulin M